Doxepin Hydrochloride Capsule
Product Images NDC 42806-533

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxepin Hydrochloride (NDC 42806-533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Epic Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg-100ct (100mg 100ct)

This text describes the usual dosage of Doxepin HCI capsules in case of mid to moderate or severe symptoms. The accompanying literature should be consulted for the complete information about the drug. The capsules must be stored in a tightly closed container away from light at controlled room temperature. Dispensing the medication guide to every patient is required. The drug has been manufactured by Epic Pharma, LLC. Each capsule contains Doxepin hydrochloride, USP equivalent to 100 mg of Doxepin. It must be kept out of the reach of children.*

FDA Label Image

10mg-100ct (10mg 100ct)

FDA Label Image

25mg-100ct (25mg 100ct)

This is a medication information for Doxepin HCI capsules. The usual dosage for mild to moderate symptomatology is 75-150 mg and for severe symptomatology is 150-300 mg. The medication should be stored in a tight, light-resistant container at room temperature. The capsules contain Doxepin ydiochiorde, which is equivalent to 25 mg of Doxepin. It is recommended to dispense with an accompanying medication guide to each patient and keep the medication out of children's reach.*

FDA Label Image

Stucture-doxepin-hcl (Stucture Doxepin HCl)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.